Rank | Gene Set | Z-score |
---|---|---|
1 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.71795392 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.64944463 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.52725035 |
4 | negative regulation of cell killing (GO:0031342) | 4.52725035 |
5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50922777 |
6 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.30381433 |
7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.24032196 |
8 | behavioral response to nicotine (GO:0035095) | 4.22651671 |
9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.07369092 |
10 | mast cell activation (GO:0045576) | 4.06224534 |
11 | neural tube formation (GO:0001841) | 3.94815519 |
12 | somite development (GO:0061053) | 3.91882629 |
13 | mast cell degranulation (GO:0043303) | 3.86576607 |
14 | mast cell activation involved in immune response (GO:0002279) | 3.86576607 |
15 | presynaptic membrane assembly (GO:0097105) | 3.85231734 |
16 | cellular extravasation (GO:0045123) | 3.83992034 |
17 | establishment of protein localization to Golgi (GO:0072600) | 3.81699475 |
18 | T cell migration (GO:0072678) | 3.78599373 |
19 | neuron fate determination (GO:0048664) | 3.77799217 |
20 | protein targeting to Golgi (GO:0000042) | 3.69530742 |
21 | nucleobase catabolic process (GO:0046113) | 3.66792567 |
22 | presynaptic membrane organization (GO:0097090) | 3.63326369 |
23 | neuron cell-cell adhesion (GO:0007158) | 3.59733431 |
24 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.59565163 |
25 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.59565163 |
26 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.59565163 |
27 | gamma-aminobutyric acid transport (GO:0015812) | 3.53665249 |
28 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.50553395 |
29 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.49006703 |
30 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.46915686 |
31 | mature B cell differentiation (GO:0002335) | 3.46897671 |
32 | negative T cell selection (GO:0043383) | 3.46859863 |
33 | neutrophil activation involved in immune response (GO:0002283) | 3.45733341 |
34 | negative thymic T cell selection (GO:0045060) | 3.41725502 |
35 | neutrophil activation (GO:0042119) | 3.40082086 |
36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.34831753 |
37 | nonmotile primary cilium assembly (GO:0035058) | 3.33415341 |
38 | retinal cone cell development (GO:0046549) | 3.32296199 |
39 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.27745964 |
40 | B cell receptor signaling pathway (GO:0050853) | 3.24894412 |
41 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.24183143 |
42 | germinal center formation (GO:0002467) | 3.23122910 |
43 | * histone H3-K4 trimethylation (GO:0080182) | 3.22773511 |
44 | axoneme assembly (GO:0035082) | 3.22151929 |
45 | respiratory burst (GO:0045730) | 3.19848670 |
46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.19646528 |
47 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.18285961 |
48 | epithelial cilium movement (GO:0003351) | 3.17456167 |
49 | centriole replication (GO:0007099) | 3.17313350 |
50 | interferon-gamma production (GO:0032609) | 3.15408154 |
51 | cellular response to interleukin-15 (GO:0071350) | 3.15119333 |
52 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.11768269 |
53 | myeloid cell activation involved in immune response (GO:0002275) | 3.10643054 |
54 | leukocyte degranulation (GO:0043299) | 3.10352092 |
55 | response to type I interferon (GO:0034340) | 3.09895777 |
56 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.09618348 |
57 | granulocyte activation (GO:0036230) | 3.09518141 |
58 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.09214379 |
59 | leukocyte aggregation (GO:0070486) | 3.08889369 |
60 | type I interferon signaling pathway (GO:0060337) | 3.07970992 |
61 | cellular response to type I interferon (GO:0071357) | 3.07970992 |
62 | neuronal action potential (GO:0019228) | 3.07543676 |
63 | postsynaptic membrane organization (GO:0001941) | 3.06158982 |
64 | microglial cell activation (GO:0001774) | 3.05765760 |
65 | dendritic cell chemotaxis (GO:0002407) | 3.05413018 |
66 | glutamate receptor signaling pathway (GO:0007215) | 3.04527812 |
67 | protein polyglutamylation (GO:0018095) | 3.03963575 |
68 | dendritic cell migration (GO:0036336) | 3.03537826 |
69 | adaptation of signaling pathway (GO:0023058) | 3.02612428 |
70 | positive T cell selection (GO:0043368) | 3.01552050 |
71 | myeloid dendritic cell activation (GO:0001773) | 3.01224073 |
72 | fucose catabolic process (GO:0019317) | 2.99168182 |
73 | L-fucose metabolic process (GO:0042354) | 2.99168182 |
74 | L-fucose catabolic process (GO:0042355) | 2.99168182 |
75 | detection of light stimulus involved in visual perception (GO:0050908) | 2.95519364 |
76 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.95519364 |
77 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.92624346 |
78 | T-helper cell differentiation (GO:0042093) | 2.92624346 |
79 | mechanosensory behavior (GO:0007638) | 2.92560816 |
80 | central nervous system neuron axonogenesis (GO:0021955) | 2.92407501 |
81 | regulation of T cell tolerance induction (GO:0002664) | 2.92071704 |
82 | positive regulation of interleukin-2 production (GO:0032743) | 2.91389238 |
83 | forebrain neuron differentiation (GO:0021879) | 2.91360237 |
84 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.90940110 |
85 | T cell selection (GO:0045058) | 2.90796992 |
86 | regulation of B cell differentiation (GO:0045577) | 2.90155428 |
87 | NIK/NF-kappaB signaling (GO:0038061) | 2.89647953 |
88 | positive thymic T cell selection (GO:0045059) | 2.89444880 |
89 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.89054947 |
90 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.89054947 |
91 | modulation by symbiont of host immune response (GO:0052553) | 2.89054947 |
92 | positive regulation by symbiont of host defense response (GO:0052509) | 2.89054947 |
93 | modulation by symbiont of host defense response (GO:0052031) | 2.89054947 |
94 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.89054947 |
95 | startle response (GO:0001964) | 2.88965690 |
96 | tolerance induction (GO:0002507) | 2.86513452 |
97 | immunoglobulin mediated immune response (GO:0016064) | 2.86308432 |
98 | regulation of regulatory T cell differentiation (GO:0045589) | 2.85823689 |
99 | alpha-beta T cell activation (GO:0046631) | 2.85678254 |
100 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.85666013 |
101 | response to muramyl dipeptide (GO:0032495) | 2.83434027 |
102 | protein localization to Golgi apparatus (GO:0034067) | 2.82594653 |
103 | positive regulation of interferon-alpha production (GO:0032727) | 2.80811361 |
104 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.80583135 |
105 | regulation of mast cell activation (GO:0033003) | 2.80309087 |
106 | auditory behavior (GO:0031223) | 2.79761239 |
107 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.79429970 |
108 | neuronal action potential propagation (GO:0019227) | 2.78973077 |
109 | response to peptidoglycan (GO:0032494) | 2.78696016 |
110 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.77451039 |
111 | limb bud formation (GO:0060174) | 2.76952255 |
112 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.76740843 |
113 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.76740843 |
114 | B cell homeostasis (GO:0001782) | 2.76031241 |
115 | cilium morphogenesis (GO:0060271) | 2.75326516 |
116 | olfactory bulb development (GO:0021772) | 2.74374602 |
117 | response to interleukin-15 (GO:0070672) | 2.73835088 |
118 | synaptic transmission, glutamatergic (GO:0035249) | 2.73439785 |
119 | lymph node development (GO:0048535) | 2.73072912 |
120 | mature B cell differentiation involved in immune response (GO:0002313) | 2.72573645 |
121 | alpha-beta T cell differentiation (GO:0046632) | 2.72516091 |
122 | protein localization to synapse (GO:0035418) | 2.72450111 |
123 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.72153616 |
124 | negative regulation of T cell mediated immunity (GO:0002710) | 2.71975149 |
125 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.71248202 |
126 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.70699127 |
127 | regulation of interferon-alpha production (GO:0032647) | 2.69391148 |
128 | positive regulation of interleukin-12 production (GO:0032735) | 2.68805330 |
129 | axonal fasciculation (GO:0007413) | 2.68751108 |
130 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.67132349 |
131 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.67132349 |
132 | regulation of meiosis I (GO:0060631) | 2.67066347 |
133 | neuron recognition (GO:0008038) | 2.66682199 |
134 | defense response to protozoan (GO:0042832) | 2.66353591 |
135 | photoreceptor cell development (GO:0042461) | 2.66128253 |
136 | dendritic spine morphogenesis (GO:0060997) | 2.65022532 |
137 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.65004458 |
138 | myeloid dendritic cell differentiation (GO:0043011) | 2.64907551 |
139 | cellular response to interferon-beta (GO:0035458) | 2.64905908 |
140 | serotonin metabolic process (GO:0042428) | 2.63991052 |
141 | protein K11-linked deubiquitination (GO:0035871) | 2.63467735 |
142 | myeloid leukocyte activation (GO:0002274) | 2.63464683 |
143 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.62912661 |
144 | positive regulation of B cell differentiation (GO:0045579) | 2.62839026 |
145 | hepatocyte apoptotic process (GO:0097284) | 2.62480779 |
146 | intraciliary transport (GO:0042073) | 2.62416888 |
147 | glycosphingolipid biosynthetic process (GO:0006688) | 2.61976143 |
148 | positive regulation of antigen processing and presentation (GO:0002579) | 2.60845437 |
149 | cilium organization (GO:0044782) | 2.60403539 |
150 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 2.59653044 |
151 | positive regulation of granulocyte differentiation (GO:0030854) | 2.58435796 |
152 | cilium movement (GO:0003341) | 2.58183164 |
153 | vocalization behavior (GO:0071625) | 2.58020620 |
154 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.57698965 |
155 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.57037859 |
156 | synapse assembly (GO:0007416) | 2.56899731 |
157 | regulation of mast cell degranulation (GO:0043304) | 2.56810289 |
158 | adult walking behavior (GO:0007628) | 2.56344797 |
159 | positive regulation of mast cell activation (GO:0033005) | 2.56342563 |
160 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.55803089 |
161 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.55373529 |
162 | thymic T cell selection (GO:0045061) | 2.55111268 |
163 | cilium assembly (GO:0042384) | 2.54733701 |
164 | activated T cell proliferation (GO:0050798) | 2.54495394 |
165 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.52948970 |
166 | eye photoreceptor cell development (GO:0042462) | 2.52786023 |
167 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.52694579 |
168 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.52694579 |
169 | T cell differentiation involved in immune response (GO:0002292) | 2.52694579 |
170 | piRNA metabolic process (GO:0034587) | 2.52289030 |
171 | protein localization to cilium (GO:0061512) | 2.50787738 |
172 | response to protozoan (GO:0001562) | 2.50517934 |
173 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.49977850 |
174 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.49977850 |
175 | positive regulation of neurological system process (GO:0031646) | 2.48302320 |
176 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.45019376 |
177 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.45019376 |
178 | transmission of nerve impulse (GO:0019226) | 2.44988397 |
179 | spinal cord motor neuron differentiation (GO:0021522) | 2.44051839 |
180 | regulation of telomere maintenance (GO:0032204) | 2.43162241 |
181 | neuron-neuron synaptic transmission (GO:0007270) | 2.42417693 |
182 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.40568273 |
183 | microtubule anchoring (GO:0034453) | 2.40032263 |
184 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.39978150 |
185 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.39470086 |
186 | dendrite morphogenesis (GO:0048813) | 2.38925151 |
187 | indolalkylamine metabolic process (GO:0006586) | 2.37581964 |
188 | photoreceptor cell maintenance (GO:0045494) | 2.37314505 |
189 | positive regulation of microtubule polymerization (GO:0031116) | 2.36949061 |
190 | regulation of action potential (GO:0098900) | 2.36489431 |
191 | dentate gyrus development (GO:0021542) | 2.36376501 |
192 | inner ear receptor stereocilium organization (GO:0060122) | 2.36332809 |
193 | regulation of cilium movement (GO:0003352) | 2.36273355 |
194 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.35478118 |
195 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.35478118 |
196 | positive regulation of synapse assembly (GO:0051965) | 2.33580055 |
197 | seminiferous tubule development (GO:0072520) | 2.33006024 |
198 | kidney morphogenesis (GO:0060993) | 2.32432792 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.27796028 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.19504639 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.95421003 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.76792215 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.65825942 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.28284205 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.07568188 |
8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.01757953 |
9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.69606172 |
10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.64565308 |
11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.59789083 |
12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.53796264 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50078847 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.42162708 |
15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.37494173 |
16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.27661335 |
17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.16961614 |
18 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.16856327 |
19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.14783178 |
20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.07907002 |
21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.05727824 |
22 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.05358030 |
23 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.04953928 |
24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03246275 |
25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.02294477 |
26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.96991278 |
27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.93549764 |
28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.88873136 |
29 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85898150 |
30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78750087 |
31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.76586936 |
32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.76527554 |
33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.76288835 |
34 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.75733660 |
35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.72427835 |
36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.68197046 |
37 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.66457404 |
38 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.63213199 |
39 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.62500133 |
40 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.61797646 |
41 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.60233837 |
42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.60213070 |
43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.59663100 |
44 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.58474002 |
45 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.56009686 |
46 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.56009686 |
47 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.53201018 |
48 | MYB_26560356_Chip-Seq_TH2_Human | 1.53148271 |
49 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52349185 |
50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.52065390 |
51 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.49221727 |
52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48413130 |
53 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.47866497 |
54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.46259913 |
55 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.45679969 |
56 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.44848801 |
57 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.43178854 |
58 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42622825 |
59 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.41694609 |
60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.41571097 |
61 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.40908093 |
62 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.39630546 |
63 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38684827 |
64 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38353132 |
65 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.38304553 |
66 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.36951030 |
67 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.36367658 |
68 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.35954416 |
69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34780808 |
70 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33933320 |
71 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.33669817 |
72 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.32921674 |
73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32642354 |
74 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.32267916 |
75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31307565 |
76 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.31102978 |
77 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.30898751 |
78 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.30205060 |
79 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.29114578 |
80 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.26544556 |
81 | EWS_26573619_Chip-Seq_HEK293_Human | 1.26337857 |
82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25930832 |
83 | MYB_26560356_Chip-Seq_TH1_Human | 1.25757055 |
84 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.25506433 |
85 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.25492946 |
86 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25336023 |
87 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.23965862 |
88 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.23729084 |
89 | FUS_26573619_Chip-Seq_HEK293_Human | 1.22403379 |
90 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.21566860 |
91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19780576 |
92 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19675642 |
93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19228019 |
94 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.19209978 |
95 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.18621967 |
96 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.18139439 |
97 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.17842019 |
98 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.17293509 |
99 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.16638400 |
100 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.15988827 |
101 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.14844174 |
102 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.14714249 |
103 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13315114 |
104 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.12695086 |
105 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.11468394 |
106 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.11442435 |
107 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.10057193 |
108 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.10042018 |
109 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.09264726 |
110 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.09017836 |
111 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08966532 |
112 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07885622 |
113 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.07122541 |
114 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06005040 |
115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05423879 |
116 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05072430 |
117 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.04752453 |
118 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.04181510 |
119 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03926642 |
120 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03315125 |
121 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.03290602 |
122 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02935419 |
123 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02773166 |
124 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02773166 |
125 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.02740109 |
126 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02731163 |
127 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02026177 |
128 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.01505019 |
129 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01468991 |
130 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.01163599 |
131 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.99433499 |
132 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.99053741 |
133 | JUN_21703547_ChIP-Seq_K562_Human | 0.98465439 |
134 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.97949921 |
135 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97942754 |
136 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.97510914 |
137 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97308380 |
138 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97298171 |
139 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97189441 |
140 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.96987345 |
141 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.96875288 |
142 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96366242 |
143 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96366242 |
144 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96196858 |
145 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95933727 |
146 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.95779420 |
147 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.93795970 |
148 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93501186 |
149 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93331574 |
150 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91855857 |
151 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91560330 |
152 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.91344180 |
153 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.91190519 |
154 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90500805 |
155 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90415953 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.36273054 |
2 | MP0005671_abnormal_response_to | 3.70764372 |
3 | * MP0008877_abnormal_DNA_methylation | 3.54166723 |
4 | MP0002148_abnormal_hypersensitivity_rea | 3.11380390 |
5 | MP0001790_abnormal_immune_system | 3.08239854 |
6 | MP0005387_immune_system_phenotype | 3.08239854 |
7 | MP0001800_abnormal_humoral_immune | 3.02366474 |
8 | MP0009785_altered_susceptibility_to | 2.89369353 |
9 | MP0005000_abnormal_immune_tolerance | 2.85885598 |
10 | MP0003436_decreased_susceptibility_to | 2.71271992 |
11 | MP0002452_abnormal_antigen_presenting | 2.68297624 |
12 | MP0000685_abnormal_immune_system | 2.65298616 |
13 | MP0000569_abnormal_digit_pigmentation | 2.65073571 |
14 | MP0002723_abnormal_immune_serum | 2.60709690 |
15 | MP0005025_abnormal_response_to | 2.53258284 |
16 | MP0001819_abnormal_immune_cell | 2.53085233 |
17 | MP0003763_abnormal_thymus_physiology | 2.52456537 |
18 | MP0002420_abnormal_adaptive_immunity | 2.51063304 |
19 | MP0002419_abnormal_innate_immunity | 2.48105719 |
20 | MP0004510_myositis | 2.33071607 |
21 | MP0002166_altered_tumor_susceptibility | 2.30634124 |
22 | MP0003724_increased_susceptibility_to | 2.21948519 |
23 | MP0005174_abnormal_tail_pigmentation | 2.18257491 |
24 | MP0002272_abnormal_nervous_system | 2.10357937 |
25 | MP0004142_abnormal_muscle_tone | 2.10170322 |
26 | MP0002006_tumorigenesis | 2.09899238 |
27 | * MP0002398_abnormal_bone_marrow | 2.05799625 |
28 | * MP0003121_genomic_imprinting | 2.02145021 |
29 | MP0000778_abnormal_nervous_system | 2.01958131 |
30 | MP0005551_abnormal_eye_electrophysiolog | 2.01080444 |
31 | MP0000015_abnormal_ear_pigmentation | 1.98254495 |
32 | MP0001486_abnormal_startle_reflex | 1.98065857 |
33 | MP0006276_abnormal_autonomic_nervous | 1.96980197 |
34 | * MP0000716_abnormal_immune_system | 1.95195898 |
35 | MP0005310_abnormal_salivary_gland | 1.93940191 |
36 | MP0003635_abnormal_synaptic_transmissio | 1.93368791 |
37 | MP0002396_abnormal_hematopoietic_system | 1.92455163 |
38 | MP0005409_darkened_coat_color | 1.89647595 |
39 | MP0003303_peritoneal_inflammation | 1.88874424 |
40 | MP0002009_preneoplasia | 1.88370447 |
41 | MP0006082_CNS_inflammation | 1.88115726 |
42 | MP0005464_abnormal_platelet_physiology | 1.85209768 |
43 | MP0004885_abnormal_endolymph | 1.84121260 |
44 | MP0008057_abnormal_DNA_replication | 1.83759599 |
45 | MP0009046_muscle_twitch | 1.83604970 |
46 | MP0010155_abnormal_intestine_physiology | 1.76102340 |
47 | MP0002405_respiratory_system_inflammati | 1.75997797 |
48 | MP0001188_hyperpigmentation | 1.75353898 |
49 | MP0001853_heart_inflammation | 1.74428577 |
50 | MP0002063_abnormal_learning/memory/cond | 1.72395965 |
51 | MP0008789_abnormal_olfactory_epithelium | 1.71193700 |
52 | * MP0003122_maternal_imprinting | 1.61625162 |
53 | * MP0000689_abnormal_spleen_morphology | 1.59786632 |
54 | MP0005394_taste/olfaction_phenotype | 1.58728640 |
55 | MP0005499_abnormal_olfactory_system | 1.58728640 |
56 | MP0001984_abnormal_olfaction | 1.57585260 |
57 | MP0002064_seizures | 1.56675480 |
58 | MP0004742_abnormal_vestibular_system | 1.55961396 |
59 | MP0003195_calcinosis | 1.55790552 |
60 | * MP0002722_abnormal_immune_system | 1.52928113 |
61 | MP0005423_abnormal_somatic_nervous | 1.52409045 |
62 | MP0003880_abnormal_central_pattern | 1.52234905 |
63 | MP0002734_abnormal_mechanical_nocicepti | 1.51697832 |
64 | MP0005646_abnormal_pituitary_gland | 1.50984220 |
65 | MP0002067_abnormal_sensory_capabilities | 1.49538195 |
66 | MP0006292_abnormal_olfactory_placode | 1.48948807 |
67 | MP0001845_abnormal_inflammatory_respons | 1.48886209 |
68 | MP0004133_heterotaxia | 1.47928003 |
69 | MP0004859_abnormal_synaptic_plasticity | 1.47834236 |
70 | MP0000703_abnormal_thymus_morphology | 1.46835652 |
71 | * MP0002429_abnormal_blood_cell | 1.46621745 |
72 | MP0002557_abnormal_social/conspecific_i | 1.45357460 |
73 | MP0004043_abnormal_pH_regulation | 1.43981982 |
74 | MP0000631_abnormal_neuroendocrine_gland | 1.43933701 |
75 | MP0001970_abnormal_pain_threshold | 1.43104558 |
76 | MP0002277_abnormal_respiratory_mucosa | 1.41159018 |
77 | MP0005386_behavior/neurological_phenoty | 1.40466811 |
78 | MP0004924_abnormal_behavior | 1.40466811 |
79 | MP0001986_abnormal_taste_sensitivity | 1.40228355 |
80 | MP0003866_abnormal_defecation | 1.39879178 |
81 | MP0006072_abnormal_retinal_apoptosis | 1.39848542 |
82 | MP0005187_abnormal_penis_morphology | 1.39075444 |
83 | MP0005075_abnormal_melanosome_morpholog | 1.36332912 |
84 | MP0002733_abnormal_thermal_nociception | 1.36252479 |
85 | MP0002138_abnormal_hepatobiliary_system | 1.35036068 |
86 | * MP0004808_abnormal_hematopoietic_stem | 1.30497062 |
87 | MP0003890_abnormal_embryonic-extraembry | 1.26779602 |
88 | MP0001533_abnormal_skeleton_physiology | 1.26616046 |
89 | MP0005253_abnormal_eye_physiology | 1.23948552 |
90 | MP0001529_abnormal_vocalization | 1.22771045 |
91 | MP0001873_stomach_inflammation | 1.16536415 |
92 | MP0001545_abnormal_hematopoietic_system | 1.11453718 |
93 | MP0005397_hematopoietic_system_phenotyp | 1.11453718 |
94 | MP0002095_abnormal_skin_pigmentation | 1.11033007 |
95 | MP0003183_abnormal_peptide_metabolism | 1.10296693 |
96 | MP0002653_abnormal_ependyma_morphology | 1.09936714 |
97 | MP0000427_abnormal_hair_cycle | 1.09293083 |
98 | MP0004270_analgesia | 1.08682229 |
99 | MP0002102_abnormal_ear_morphology | 1.07573318 |
100 | MP0005379_endocrine/exocrine_gland_phen | 1.06343074 |
101 | MP0000955_abnormal_spinal_cord | 1.05890825 |
102 | MP0002163_abnormal_gland_morphology | 1.05537701 |
103 | MP0009333_abnormal_splenocyte_physiolog | 1.05316834 |
104 | MP0001485_abnormal_pinna_reflex | 1.05052206 |
105 | MP0005084_abnormal_gallbladder_morpholo | 1.04158719 |
106 | MP0001851_eye_inflammation | 1.03381534 |
107 | MP0002184_abnormal_innervation | 1.02993644 |
108 | MP0002882_abnormal_neuron_morphology | 1.02924216 |
109 | MP0004947_skin_inflammation | 1.01433917 |
110 | MP0002752_abnormal_somatic_nervous | 1.01304844 |
111 | MP0002928_abnormal_bile_duct | 1.01261818 |
112 | MP0003300_gastrointestinal_ulcer | 1.00437074 |
113 | MP0009764_decreased_sensitivity_to | 0.98653089 |
114 | MP0003828_pulmonary_edema | 0.97976700 |
115 | MP0002933_joint_inflammation | 0.97505637 |
116 | MP0002751_abnormal_autonomic_nervous | 0.97126652 |
117 | MP0003938_abnormal_ear_development | 0.96730302 |
118 | MP0002234_abnormal_pharynx_morphology | 0.95130680 |
119 | MP0008469_abnormal_protein_level | 0.95101237 |
120 | MP0000465_gastrointestinal_hemorrhage | 0.93434170 |
121 | MP0002998_abnormal_bone_remodeling | 0.92114986 |
122 | MP0008872_abnormal_physiological_respon | 0.90255092 |
123 | MP0005195_abnormal_posterior_eye | 0.89655693 |
124 | MP0004381_abnormal_hair_follicle | 0.88825048 |
125 | MP0002152_abnormal_brain_morphology | 0.87820351 |
126 | MP0004811_abnormal_neuron_physiology | 0.87642187 |
127 | MP0000490_abnormal_crypts_of | 0.87457109 |
128 | * MP0003787_abnormal_imprinting | 0.86186069 |
129 | MP0003698_abnormal_male_reproductive | 0.84323087 |
130 | MP0000049_abnormal_middle_ear | 0.83523768 |
131 | MP0003448_altered_tumor_morphology | 0.83034731 |
132 | MP0002822_catalepsy | 0.82769689 |
133 | MP0000647_abnormal_sebaceous_gland | 0.82105712 |
134 | MP0001501_abnormal_sleep_pattern | 0.81164006 |
135 | MP0003633_abnormal_nervous_system | 0.80792644 |
136 | MP0002909_abnormal_adrenal_gland | 0.80472723 |
137 | MP0002735_abnormal_chemical_nociception | 0.79974732 |
138 | MP0000026_abnormal_inner_ear | 0.79889321 |
139 | * MP0002066_abnormal_motor_capabilities/c | 0.78139697 |
140 | MP0005171_absent_coat_pigmentation | 0.78116895 |
141 | MP0001963_abnormal_hearing_physiology | 0.75863940 |
142 | MP0002229_neurodegeneration | 0.73935166 |
143 | MP0001919_abnormal_reproductive_system | 0.73156114 |
144 | MP0001324_abnormal_eye_pigmentation | 0.73040784 |
145 | MP0009745_abnormal_behavioral_response | 0.71285708 |
146 | MP0004147_increased_porphyrin_level | 0.70922912 |
147 | * MP0001929_abnormal_gametogenesis | 0.70140017 |
148 | MP0003631_nervous_system_phenotype | 0.69017183 |
149 | MP0008569_lethality_at_weaning | 0.68876874 |
150 | MP0001905_abnormal_dopamine_level | 0.68847050 |
151 | MP0005248_abnormal_Harderian_gland | 0.68738876 |
152 | MP0000858_altered_metastatic_potential | 0.67845333 |
153 | MP0002069_abnormal_eating/drinking_beha | 0.65955844 |
154 | MP0008058_abnormal_DNA_repair | 0.65250938 |
155 | MP0010386_abnormal_urinary_bladder | 0.64815022 |
156 | MP0000343_altered_response_to | 0.62348287 |
157 | MP0002638_abnormal_pupillary_reflex | 0.61962777 |
158 | MP0002254_reproductive_system_inflammat | 0.61952295 |
159 | MP0001502_abnormal_circadian_rhythm | 0.61475780 |
160 | MP0009278_abnormal_bone_marrow | 0.61191471 |
161 | MP0001440_abnormal_grooming_behavior | 0.59737647 |
162 | MP0005645_abnormal_hypothalamus_physiol | 0.59505726 |
163 | MP0009763_increased_sensitivity_to | 0.57501680 |
164 | MP0002876_abnormal_thyroid_physiology | 0.57432926 |
165 | MP0008995_early_reproductive_senescence | 0.56656605 |
166 | MP0005390_skeleton_phenotype | 0.55027213 |
167 | MP0004883_abnormal_blood_vessel | 0.54845965 |
168 | MP0001968_abnormal_touch/_nociception | 0.53568556 |
169 | MP0002736_abnormal_nociception_after | 0.51046036 |
170 | MP0003136_yellow_coat_color | 0.51012218 |
171 | MP0002572_abnormal_emotion/affect_behav | 0.48661305 |
172 | MP0002693_abnormal_pancreas_physiology | 0.46681873 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 4.82704469 |
2 | Recurrent bacterial skin infections (HP:0005406) | 4.33214438 |
3 | Eczematoid dermatitis (HP:0000976) | 4.13438464 |
4 | Hyperventilation (HP:0002883) | 4.08716370 |
5 | Recurrent fungal infections (HP:0002841) | 3.99207105 |
6 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.94873294 |
7 | Recurrent cutaneous fungal infections (HP:0011370) | 3.94873294 |
8 | Agammaglobulinemia (HP:0004432) | 3.85549096 |
9 | Pancreatic cysts (HP:0001737) | 3.85469370 |
10 | Prostate neoplasm (HP:0100787) | 3.66130504 |
11 | Pancreatic fibrosis (HP:0100732) | 3.66061894 |
12 | Abnormality of midbrain morphology (HP:0002418) | 3.62027950 |
13 | Molar tooth sign on MRI (HP:0002419) | 3.62027950 |
14 | Abnormality of the fingertips (HP:0001211) | 3.57557229 |
15 | Focal motor seizures (HP:0011153) | 3.49367056 |
16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.46443152 |
17 | Panhypogammaglobulinemia (HP:0003139) | 3.45185534 |
18 | Recurrent viral infections (HP:0004429) | 3.44296909 |
19 | True hermaphroditism (HP:0010459) | 3.42495244 |
20 | Obstructive lung disease (HP:0006536) | 3.38660248 |
21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.38660248 |
22 | Retrobulbar optic neuritis (HP:0100654) | 3.36824062 |
23 | Optic neuritis (HP:0100653) | 3.36824062 |
24 | Recurrent skin infections (HP:0001581) | 3.32630298 |
25 | Thyroiditis (HP:0100646) | 3.31230757 |
26 | Medial flaring of the eyebrow (HP:0010747) | 3.30662929 |
27 | Meningitis (HP:0001287) | 3.27748601 |
28 | Mediastinal lymphadenopathy (HP:0100721) | 3.26773364 |
29 | Myositis (HP:0100614) | 3.25996302 |
30 | Vasculitis (HP:0002633) | 3.13114149 |
31 | Progressive cerebellar ataxia (HP:0002073) | 3.11006473 |
32 | Nephronophthisis (HP:0000090) | 3.09994786 |
33 | Abnormality of the prostate (HP:0008775) | 3.08604698 |
34 | Gait imbalance (HP:0002141) | 3.04847211 |
35 | IgM deficiency (HP:0002850) | 2.99429046 |
36 | Focal seizures (HP:0007359) | 2.99255638 |
37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.91272783 |
38 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.89985446 |
39 | Volvulus (HP:0002580) | 2.87641206 |
40 | Drooling (HP:0002307) | 2.87076353 |
41 | Atonic seizures (HP:0010819) | 2.81227263 |
42 | Congenital stationary night blindness (HP:0007642) | 2.80664490 |
43 | Chronic otitis media (HP:0000389) | 2.80074328 |
44 | Stomatitis (HP:0010280) | 2.79117211 |
45 | Genetic anticipation (HP:0003743) | 2.78553763 |
46 | Orchitis (HP:0100796) | 2.77122853 |
47 | Abnormality of T cell number (HP:0011839) | 2.72896775 |
48 | Broad-based gait (HP:0002136) | 2.72246745 |
49 | Excessive salivation (HP:0003781) | 2.71667601 |
50 | Abnormality of the renal medulla (HP:0100957) | 2.71382597 |
51 | Congenital primary aphakia (HP:0007707) | 2.71163826 |
52 | Limb dystonia (HP:0002451) | 2.69410090 |
53 | Lip pit (HP:0100267) | 2.68206131 |
54 | T lymphocytopenia (HP:0005403) | 2.67429593 |
55 | Chronic hepatic failure (HP:0100626) | 2.64844471 |
56 | Chronic diarrhea (HP:0002028) | 2.60711038 |
57 | Colitis (HP:0002583) | 2.60560501 |
58 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.60290540 |
59 | Increased IgM level (HP:0003496) | 2.60144581 |
60 | Inflammation of the large intestine (HP:0002037) | 2.59683139 |
61 | Severe combined immunodeficiency (HP:0004430) | 2.58082711 |
62 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.55573213 |
63 | Absent speech (HP:0001344) | 2.55421405 |
64 | Leukocytosis (HP:0001974) | 2.54681450 |
65 | Abnormal hair whorl (HP:0010721) | 2.53867714 |
66 | Chromsome breakage (HP:0040012) | 2.53561396 |
67 | Pulmonary infiltrates (HP:0002113) | 2.52918384 |
68 | Nephrogenic diabetes insipidus (HP:0009806) | 2.52725747 |
69 | Oligodactyly (hands) (HP:0001180) | 2.52626638 |
70 | Encephalitis (HP:0002383) | 2.52495435 |
71 | Abnormality of eosinophils (HP:0001879) | 2.51912090 |
72 | Dialeptic seizures (HP:0011146) | 2.51457286 |
73 | IgG deficiency (HP:0004315) | 2.50878224 |
74 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.49706796 |
75 | Protruding tongue (HP:0010808) | 2.47463908 |
76 | Eosinophilia (HP:0001880) | 2.47132216 |
77 | Gaze-evoked nystagmus (HP:0000640) | 2.46518438 |
78 | Cellulitis (HP:0100658) | 2.45912204 |
79 | Recurrent bronchitis (HP:0002837) | 2.45733374 |
80 | Pustule (HP:0200039) | 2.45701999 |
81 | Lissencephaly (HP:0001339) | 2.45125832 |
82 | Abnormality of the labia minora (HP:0012880) | 2.44991182 |
83 | Recurrent pneumonia (HP:0006532) | 2.43435373 |
84 | Abnormality of the renal cortex (HP:0011035) | 2.42129505 |
85 | Abnormality of macrophages (HP:0004311) | 2.40598165 |
86 | Prolonged bleeding time (HP:0003010) | 2.40270884 |
87 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.39350858 |
88 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.39350858 |
89 | Abnormality of T cells (HP:0002843) | 2.38639871 |
90 | Chronic sinusitis (HP:0011109) | 2.38597284 |
91 | Genital tract atresia (HP:0001827) | 2.37025117 |
92 | Keratoconjunctivitis sicca (HP:0001097) | 2.36878419 |
93 | Gastrointestinal stroma tumor (HP:0100723) | 2.36281946 |
94 | Lymphopenia (HP:0001888) | 2.35733578 |
95 | Pachygyria (HP:0001302) | 2.31753831 |
96 | Type II lissencephaly (HP:0007260) | 2.30413801 |
97 | Spontaneous hematomas (HP:0007420) | 2.29690049 |
98 | Epileptic encephalopathy (HP:0200134) | 2.29298126 |
99 | Hepatoblastoma (HP:0002884) | 2.29271301 |
100 | Cystic liver disease (HP:0006706) | 2.28101329 |
101 | Recurrent sinusitis (HP:0011108) | 2.28095628 |
102 | Gastrointestinal inflammation (HP:0004386) | 2.27510378 |
103 | Attenuation of retinal blood vessels (HP:0007843) | 2.25514700 |
104 | Gingivitis (HP:0000230) | 2.24222717 |
105 | Vaginal atresia (HP:0000148) | 2.23855597 |
106 | Colon cancer (HP:0003003) | 2.22884276 |
107 | Abnormality of B cell number (HP:0010975) | 2.21706006 |
108 | B lymphocytopenia (HP:0010976) | 2.21706006 |
109 | Granulocytopenia (HP:0001913) | 2.19908433 |
110 | Hypochromic microcytic anemia (HP:0004840) | 2.19638766 |
111 | Abolished electroretinogram (ERG) (HP:0000550) | 2.19062296 |
112 | Arterial thrombosis (HP:0004420) | 2.18832434 |
113 | Polyphagia (HP:0002591) | 2.18585272 |
114 | Keratoconjunctivitis (HP:0001096) | 2.18379776 |
115 | Periodontitis (HP:0000704) | 2.18279496 |
116 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.18202400 |
117 | Recurrent lower respiratory tract infections (HP:0002783) | 2.15372051 |
118 | Basal ganglia calcification (HP:0002135) | 2.14695127 |
119 | Generalized hypopigmentation of hair (HP:0011358) | 2.14346888 |
120 | Hypothermia (HP:0002045) | 2.14137518 |
121 | Autoimmune hemolytic anemia (HP:0001890) | 2.13863000 |
122 | Absent frontal sinuses (HP:0002688) | 2.13722004 |
123 | Inability to walk (HP:0002540) | 2.13082570 |
124 | Thyroid-stimulating hormone excess (HP:0002925) | 2.12839096 |
125 | Autoimmune thrombocytopenia (HP:0001973) | 2.09599826 |
126 | Poor coordination (HP:0002370) | 2.08869176 |
127 | Hemoptysis (HP:0002105) | 2.08142754 |
128 | Abnormality of the corticospinal tract (HP:0002492) | 2.06454089 |
129 | Anencephaly (HP:0002323) | 2.05996994 |
130 | Acute myeloid leukemia (HP:0004808) | 2.04920513 |
131 | Tented upper lip vermilion (HP:0010804) | 2.04816502 |
132 | Absence seizures (HP:0002121) | 2.04184358 |
133 | Febrile seizures (HP:0002373) | 2.03944927 |
134 | Optic nerve hypoplasia (HP:0000609) | 2.03319118 |
135 | Papillary thyroid carcinoma (HP:0002895) | 2.02722671 |
136 | Fair hair (HP:0002286) | 2.01761589 |
137 | Dyskinesia (HP:0100660) | 2.01251295 |
138 | Hemiparesis (HP:0001269) | 1.99665596 |
139 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.99331737 |
140 | Renal cortical cysts (HP:0000803) | 1.98936280 |
141 | Amyotrophic lateral sclerosis (HP:0007354) | 1.98581387 |
142 | Stomach cancer (HP:0012126) | 1.97468722 |
143 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.96990670 |
144 | Combined immunodeficiency (HP:0005387) | 1.96801959 |
145 | Abnormality of T cell physiology (HP:0011840) | 1.96418673 |
146 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.94639709 |
147 | White forelock (HP:0002211) | 1.94421765 |
148 | Epistaxis (HP:0000421) | 1.93718980 |
149 | Abnormal ciliary motility (HP:0012262) | 1.92964483 |
150 | Agitation (HP:0000713) | 1.92724275 |
151 | Narrow forehead (HP:0000341) | 1.92064876 |
152 | Decreased central vision (HP:0007663) | 1.91694314 |
153 | Widely spaced teeth (HP:0000687) | 1.91385790 |
154 | Absent/shortened dynein arms (HP:0200106) | 1.90888923 |
155 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.90888923 |
156 | Agnosia (HP:0010524) | 1.90885872 |
157 | Postaxial hand polydactyly (HP:0001162) | 1.90819908 |
158 | Congenital hepatic fibrosis (HP:0002612) | 1.90321490 |
159 | Cheilitis (HP:0100825) | 1.87535901 |
160 | Petechiae (HP:0000967) | 1.86751414 |
161 | Osteomyelitis (HP:0002754) | 1.86532370 |
162 | Abnormality of male internal genitalia (HP:0000022) | 1.86025541 |
163 | Progressive inability to walk (HP:0002505) | 1.85896991 |
164 | Increased IgE level (HP:0003212) | 1.85731568 |
165 | Specific learning disability (HP:0001328) | 1.85112864 |
166 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.83953143 |
167 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.83953143 |
168 | Vacuolated lymphocytes (HP:0001922) | 1.82426778 |
169 | Growth hormone deficiency (HP:0000824) | 1.82194518 |
170 | Patchy hypopigmentation of hair (HP:0011365) | 1.81221444 |
171 | Lymphoma (HP:0002665) | 1.81041286 |
172 | Postaxial foot polydactyly (HP:0001830) | 1.80425609 |
173 | Aplasia cutis congenita (HP:0001057) | 1.80089477 |
174 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.80021770 |
175 | Clubbing of toes (HP:0100760) | 1.79785869 |
176 | Broad alveolar ridges (HP:0000187) | 1.79785685 |
177 | Systemic lupus erythematosus (HP:0002725) | 1.78439991 |
178 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.78139659 |
179 | Hypergammaglobulinemia (HP:0010702) | 1.77317130 |
180 | Sclerocornea (HP:0000647) | 1.76300826 |
181 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.75793051 |
182 | Pendular nystagmus (HP:0012043) | 1.75603478 |
183 | Sepsis (HP:0100806) | 1.75510646 |
184 | Abnormality of the nasal septum (HP:0000419) | 1.74726580 |
185 | Median cleft lip (HP:0000161) | 1.74288462 |
186 | Male pseudohermaphroditism (HP:0000037) | 1.72483909 |
187 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.71868371 |
188 | Inappropriate behavior (HP:0000719) | 1.68408669 |
189 | Neoplasm of the oral cavity (HP:0100649) | 1.67756976 |
190 | Truncal obesity (HP:0001956) | 1.67348001 |
191 | Polydipsia (HP:0001959) | 1.67331349 |
192 | Abnormal drinking behavior (HP:0030082) | 1.67331349 |
193 | Myokymia (HP:0002411) | 1.66291395 |
194 | Short foot (HP:0001773) | 1.65734857 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MARK1 | 4.05944273 |
2 | RIPK4 | 3.69634478 |
3 | FRK | 3.64444979 |
4 | MAP3K14 | 3.58307274 |
5 | TXK | 3.38924086 |
6 | IRAK4 | 3.08712411 |
7 | WNK3 | 2.69959567 |
8 | PNCK | 2.53325588 |
9 | NUAK1 | 2.45719439 |
10 | MAP3K4 | 2.35833991 |
11 | TNIK | 2.33226671 |
12 | MAP4K1 | 2.28332225 |
13 | IKBKE | 2.16134674 |
14 | TEC | 2.14995010 |
15 | KIT | 2.09881970 |
16 | TAOK3 | 2.02977643 |
17 | TYK2 | 2.02348279 |
18 | BLK | 1.95309298 |
19 | BMPR2 | 1.92308847 |
20 | BCR | 1.89356874 |
21 | JAK3 | 1.84427807 |
22 | GRK7 | 1.83398273 |
23 | MAP3K9 | 1.82730923 |
24 | NTRK2 | 1.81688944 |
25 | MAP3K13 | 1.77277453 |
26 | IKBKB | 1.71312429 |
27 | MAP4K2 | 1.68738852 |
28 | PIK3CA | 1.66085861 |
29 | IRAK3 | 1.61868791 |
30 | PINK1 | 1.61060303 |
31 | CASK | 1.58659391 |
32 | TRIM28 | 1.54519532 |
33 | SYK | 1.53193933 |
34 | PIK3CG | 1.50762737 |
35 | FES | 1.48292579 |
36 | JAK1 | 1.46516194 |
37 | CDK3 | 1.45636517 |
38 | SIK2 | 1.38483387 |
39 | TBK1 | 1.38272650 |
40 | DYRK2 | 1.34892260 |
41 | PAK3 | 1.32589682 |
42 | CHUK | 1.31075243 |
43 | YES1 | 1.29698279 |
44 | SIK3 | 1.27211979 |
45 | NEK6 | 1.23813336 |
46 | CSK | 1.23419366 |
47 | CDK19 | 1.21861433 |
48 | LCK | 1.21279932 |
49 | ITK | 1.21265282 |
50 | BTK | 1.19936615 |
51 | ZAP70 | 1.18568736 |
52 | ACVR1B | 1.17970170 |
53 | MST4 | 1.17203408 |
54 | ADRBK2 | 1.16197414 |
55 | DMPK | 1.14210135 |
56 | CAMKK2 | 1.12695697 |
57 | LYN | 1.11430656 |
58 | HCK | 1.10038419 |
59 | NLK | 1.05275889 |
60 | CSNK1G2 | 1.04479519 |
61 | CLK1 | 1.02021102 |
62 | PRKCQ | 0.97731031 |
63 | MAP2K7 | 0.96425076 |
64 | TGFBR2 | 0.96314814 |
65 | MAP2K4 | 0.96126686 |
66 | PIM1 | 0.94654252 |
67 | FGFR3 | 0.92795301 |
68 | MAP3K12 | 0.92270142 |
69 | MUSK | 0.91317240 |
70 | OXSR1 | 0.89091906 |
71 | SGK494 | 0.87421808 |
72 | SGK223 | 0.87421808 |
73 | MAPK13 | 0.87000364 |
74 | MINK1 | 0.86240582 |
75 | PRKCG | 0.86091709 |
76 | FGR | 0.85827429 |
77 | CSF1R | 0.85502846 |
78 | TNK2 | 0.84280533 |
79 | MKNK2 | 0.82318742 |
80 | EPHA3 | 0.80379341 |
81 | MAP3K6 | 0.79163093 |
82 | CSNK1G1 | 0.79007141 |
83 | GRK6 | 0.78232874 |
84 | CSNK1A1L | 0.77205178 |
85 | INSRR | 0.77107412 |
86 | IRAK1 | 0.76830391 |
87 | EIF2AK2 | 0.75932472 |
88 | EPHA4 | 0.75839452 |
89 | STK24 | 0.75110440 |
90 | CSNK1G3 | 0.73442248 |
91 | CAMK1G | 0.72883249 |
92 | BMPR1B | 0.72227590 |
93 | PRPF4B | 0.71792736 |
94 | CAMK4 | 0.71027083 |
95 | SGK2 | 0.70967874 |
96 | DYRK3 | 0.70769936 |
97 | MATK | 0.69120400 |
98 | STK10 | 0.69092908 |
99 | MARK2 | 0.66714481 |
100 | DYRK1A | 0.66011355 |
101 | UHMK1 | 0.65475907 |
102 | ZAK | 0.64533048 |
103 | KSR1 | 0.64146564 |
104 | MARK3 | 0.63810660 |
105 | MAPK7 | 0.63788386 |
106 | MKNK1 | 0.63738074 |
107 | TLK1 | 0.62157566 |
108 | BRD4 | 0.61230211 |
109 | NEK9 | 0.59899563 |
110 | STK11 | 0.59337872 |
111 | DAPK2 | 0.58057446 |
112 | PLK2 | 0.57814160 |
113 | MAPK15 | 0.57231650 |
114 | SRPK1 | 0.56967533 |
115 | TAOK1 | 0.56928989 |
116 | ADRBK1 | 0.56197180 |
117 | CCNB1 | 0.56087687 |
118 | ERBB3 | 0.55902371 |
119 | CAMK1 | 0.55860743 |
120 | PRKCZ | 0.54595902 |
121 | AKT3 | 0.53531517 |
122 | PKN1 | 0.53268923 |
123 | TIE1 | 0.53114497 |
124 | CAMK2A | 0.52934793 |
125 | STK4 | 0.52908524 |
126 | CDK5 | 0.52047034 |
127 | GRK1 | 0.51710858 |
128 | IRAK2 | 0.51500166 |
129 | SGK1 | 0.47749431 |
130 | TRPM7 | 0.47140525 |
131 | WNK4 | 0.46220956 |
132 | STK39 | 0.44915751 |
133 | STK16 | 0.44445964 |
134 | RAF1 | 0.44107705 |
135 | CSNK1D | 0.43706116 |
136 | SGK3 | 0.43118717 |
137 | MAPK12 | 0.42531552 |
138 | JAK2 | 0.40191783 |
139 | PRKACA | 0.39722138 |
140 | CAMKK1 | 0.38152455 |
141 | TYRO3 | 0.37912178 |
142 | FYN | 0.36532572 |
143 | ABL1 | 0.35480490 |
144 | PRKG1 | 0.35431292 |
145 | HIPK2 | 0.35201851 |
146 | PRKCE | 0.33824997 |
147 | IGF1R | 0.33213804 |
148 | ERBB2 | 0.32921582 |
149 | NTRK3 | 0.32689379 |
150 | RPS6KA5 | 0.32189504 |
151 | MAPKAPK5 | 0.30905407 |
152 | CDK9 | 0.30529380 |
153 | MAPKAPK2 | 0.29946382 |
154 | PDGFRB | 0.28752506 |
155 | VRK1 | 0.28692029 |
156 | PRKD2 | 0.28609550 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.82288280 |
2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.50690552 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.32237393 |
4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.26675735 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.24609411 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.23145195 |
7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.11451608 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 2.10084050 |
9 | Measles_Homo sapiens_hsa05162 | 2.05805200 |
10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.04397061 |
11 | GABAergic synapse_Homo sapiens_hsa04727 | 1.98562763 |
12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.87417518 |
13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.86904161 |
14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.80995381 |
15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.80696521 |
16 | Protein export_Homo sapiens_hsa03060 | 1.75346895 |
17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.74403921 |
18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.72930694 |
19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.72750130 |
20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67693987 |
21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.67255762 |
22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62335362 |
23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.61165149 |
24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.58285858 |
25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.54214400 |
26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54153225 |
27 | Long-term depression_Homo sapiens_hsa04730 | 1.52121608 |
28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.52087539 |
29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.50883245 |
30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46807242 |
31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.46375136 |
32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40192567 |
33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.40182696 |
34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38347308 |
35 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.35806953 |
36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.31487188 |
37 | Influenza A_Homo sapiens_hsa05164 | 1.31074380 |
38 | Nicotine addiction_Homo sapiens_hsa05033 | 1.27490373 |
39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.26500230 |
40 | Pertussis_Homo sapiens_hsa05133 | 1.25245772 |
41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25186635 |
42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24244468 |
43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23214708 |
44 | Tuberculosis_Homo sapiens_hsa05152 | 1.22287430 |
45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22250494 |
46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.21906599 |
47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21652846 |
48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.17177623 |
49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.13783815 |
50 | RNA degradation_Homo sapiens_hsa03018 | 1.13668865 |
51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12832026 |
52 | Asthma_Homo sapiens_hsa05310 | 1.11289717 |
53 | Insulin secretion_Homo sapiens_hsa04911 | 1.08749531 |
54 | Malaria_Homo sapiens_hsa05144 | 1.03069786 |
55 | Platelet activation_Homo sapiens_hsa04611 | 1.01639223 |
56 | Hepatitis B_Homo sapiens_hsa05161 | 0.99860713 |
57 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.99269450 |
58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.99069896 |
59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.98397091 |
60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.96684670 |
61 | Salmonella infection_Homo sapiens_hsa05132 | 0.96438913 |
62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94688334 |
63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93473843 |
64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.93177390 |
65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93003060 |
66 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.92776028 |
67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.91096208 |
68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91060284 |
69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.90845804 |
70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.89328281 |
71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88266870 |
72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86699010 |
73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.84409787 |
74 | Phototransduction_Homo sapiens_hsa04744 | 0.84023295 |
75 | Morphine addiction_Homo sapiens_hsa05032 | 0.83729361 |
76 | Parkinsons disease_Homo sapiens_hsa05012 | 0.83372168 |
77 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80605713 |
78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78968370 |
79 | Axon guidance_Homo sapiens_hsa04360 | 0.78077586 |
80 | Apoptosis_Homo sapiens_hsa04210 | 0.76616235 |
81 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.76589898 |
82 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.76229544 |
83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76138830 |
84 | Hepatitis C_Homo sapiens_hsa05160 | 0.76123816 |
85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75586110 |
86 | Renin secretion_Homo sapiens_hsa04924 | 0.74997609 |
87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74797981 |
88 | ABC transporters_Homo sapiens_hsa02010 | 0.74643549 |
89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71221868 |
90 | Shigellosis_Homo sapiens_hsa05131 | 0.69844646 |
91 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.68406406 |
92 | Taste transduction_Homo sapiens_hsa04742 | 0.66496890 |
93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65770859 |
94 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64763906 |
95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64173520 |
96 | Peroxisome_Homo sapiens_hsa04146 | 0.63925784 |
97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63748862 |
98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63479270 |
99 | Phagosome_Homo sapiens_hsa04145 | 0.62595610 |
100 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.62591370 |
101 | Legionellosis_Homo sapiens_hsa05134 | 0.61711150 |
102 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60988886 |
103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60124694 |
104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59675590 |
105 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59637190 |
106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.59455542 |
107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59294510 |
108 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.59096879 |
109 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57559602 |
110 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57315289 |
111 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56593226 |
112 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.56404157 |
113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56307541 |
114 | Salivary secretion_Homo sapiens_hsa04970 | 0.55486700 |
115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54955603 |
116 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54707385 |
117 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54575778 |
118 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54429238 |
119 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.53945323 |
120 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.53222490 |
121 | Homologous recombination_Homo sapiens_hsa03440 | 0.52437612 |
122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52402462 |
123 | Basal transcription factors_Homo sapiens_hsa03022 | 0.52115588 |
124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52085583 |
125 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52081100 |
126 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50878703 |
127 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50275842 |
128 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50049345 |
129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50046207 |
130 | Prostate cancer_Homo sapiens_hsa05215 | 0.49986639 |
131 | Circadian entrainment_Homo sapiens_hsa04713 | 0.49768286 |
132 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49635403 |
133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49394978 |
134 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49338809 |
135 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48772323 |
136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48654852 |
137 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48276752 |
138 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46362063 |
139 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46356791 |
140 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.45818969 |
141 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45694686 |
142 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45030293 |
143 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44981228 |
144 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.44973740 |
145 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44922070 |
146 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43516895 |
147 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43360140 |
148 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.41514137 |
149 | Gap junction_Homo sapiens_hsa04540 | 0.40257277 |
150 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.39109229 |
151 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38695060 |
152 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38345043 |
153 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37489228 |
154 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.36537943 |
155 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.34947662 |